• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统性红斑狼疮患者 B 淋巴细胞中白细胞相关免疫球蛋白样受体 1 的表达和功能缺陷。

Defective expression and function of the leukocyte associated Ig-like receptor 1 in B lymphocytes from systemic lupus erythematosus patients.

机构信息

Department of Internal Medicine, University of Genoa, Genoa, Italy.

出版信息

PLoS One. 2012;7(2):e31903. doi: 10.1371/journal.pone.0031903. Epub 2012 Feb 15.

DOI:10.1371/journal.pone.0031903
PMID:22355402
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3280211/
Abstract

Systemic lupus erythematosus (SLE) is characterized by the production of a wide array of autoantibodies and dysregulation of B cell function. The leukocyte associated Immunoglobulin (Ig)-like receptor (LAIR)1 is a transmembrane molecule belonging to Ig superfamily which binds to different types of collagen. Herein, we have determined the expression and function of LAIR1 on B lymphocyte from SLE patients. LAIR1 expression in peripheral blood B lymphocytes from 54 SLE, 24 mixed connective tissue disease (MCTD), 20 systemic sclerosis (SSc) patients, 14 rheumatoid arthritis (RA) and 40 sex and age matched healthy donors (HD) have been analyzed by immunofluorescence. The effect of LAIR1 ligation by specific monoclonal antibodies, collagen or collagen producing mesenchymal stromal cells from reactive lymph nodes or bone marrow on Ig production by pokeweed mitogen and B cell receptor (BCR)-mediated NF-kB activation was assessed by ELISA and TransAM assay. The percentage of CD20(+) B lymphocytes lacking or showing reduced expression of LAIR1 was markedly increased in SLE and MCTD but not in SSc or RA patients compared to HD. The downregulation of LAIR1 expression was not dependent on corticosteroid therapy. Interestingly, LAIR1 engagement by collagen or collagen-producing mesenchymal stromal cells in SLE patients with low LAIR1 expression on B cells delivered a lower inhibiting signal on Ig production. In addition, NF-kB p65 subunit activation upon BCR and LAIR1 co-engagement was less inhibited in SLE patients than in HD. Our findings indicate defective LAIR1 expression and function in SLE B lymphocytes, possible contributing to an altered control of B lymphocytes behavior.

摘要

系统性红斑狼疮(SLE)的特征是产生广泛的自身抗体和 B 细胞功能失调。白细胞相关免疫球蛋白(Ig)样受体(LAIR)1 是一种跨膜分子,属于 Ig 超家族,可与不同类型的胶原蛋白结合。在此,我们确定了 SLE 患者 B 淋巴细胞上 LAIR1 的表达和功能。通过免疫荧光分析了 54 例 SLE、24 例混合性结缔组织病(MCTD)、20 例系统性硬化症(SSc)患者、14 例类风湿关节炎(RA)和 40 名性别和年龄匹配的健康供体(HD)外周血 B 淋巴细胞中 LAIR1 的表达。通过 ELISA 和 TransAM 测定评估了特异性单克隆抗体、胶原蛋白或反应性淋巴结或骨髓中的胶原蛋白产生间充质基质细胞对植物血凝素和 B 细胞受体(BCR)介导的 NF-κB 激活诱导的 Ig 产生的 LAIR1 结合作用。与 HD 相比,SLE 和 MCTD 患者中缺乏或表达降低的 CD20+ B 淋巴细胞的 LAIR1 百分比明显增加,但 SSc 或 RA 患者则没有。LAIR1 表达的下调不依赖于皮质类固醇治疗。有趣的是,在 LAIR1 表达较低的 SLE 患者中,胶原蛋白或胶原蛋白产生的间充质基质细胞与 LAIR1 的结合传递了较低的抑制 Ig 产生信号。此外,与 HD 相比,SLE 患者中 BCR 和 LAIR1 共结合时 NF-κB p65 亚基的激活抑制作用较弱。我们的研究结果表明,SLE B 淋巴细胞中存在缺陷的 LAIR1 表达和功能,可能导致 B 淋巴细胞行为的控制异常。

相似文献

1
Defective expression and function of the leukocyte associated Ig-like receptor 1 in B lymphocytes from systemic lupus erythematosus patients.系统性红斑狼疮患者 B 淋巴细胞中白细胞相关免疫球蛋白样受体 1 的表达和功能缺陷。
PLoS One. 2012;7(2):e31903. doi: 10.1371/journal.pone.0031903. Epub 2012 Feb 15.
2
B-cell proliferation and differentiation in systemic lupus erythematosus and mixed connective tissue disease.系统性红斑狼疮和混合性结缔组织病中的B细胞增殖与分化
J Clin Lab Immunol. 1988 Jun;26(2):55-61.
3
BTLA Expression and Function Are Impaired on SLE B Cells.系统性红斑狼疮 B 细胞上 BTLA 的表达和功能受损。
Front Immunol. 2021 Apr 22;12:667991. doi: 10.3389/fimmu.2021.667991. eCollection 2021.
4
Decreased CD161+CD8+ T cells in the peripheral blood of patients suffering from rheumatic diseases.风湿性疾病患者外周血中CD161+CD8+ T细胞减少。
Rheumatology (Oxford). 2006 Dec;45(12):1477-84. doi: 10.1093/rheumatology/kel119. Epub 2006 Apr 25.
5
Variety of endosomal TLRs and Interferons (IFN-α, IFN-β, IFN-γ) expression profiles in patients with SLE, SSc and MCTD.SLE、SSc 和 MCTD 患者的内体 TLR 和干扰素(IFN-α、IFN-β、IFN-γ)表达谱的多样性。
Clin Exp Immunol. 2021 Apr;204(1):49-63. doi: 10.1111/cei.13566. Epub 2021 Jan 17.
6
Antibody penetration into living cells. I. Intranuclear immunoglobulin in peripheral blood mononuclear cells in mixed connective tissue disease and systemic lupus erythematosus.抗体渗入活细胞。I. 混合性结缔组织病和系统性红斑狼疮患者外周血单个核细胞中的核内免疫球蛋白
Clin Exp Immunol. 1979 Mar;35(3):364-75.
7
Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.肿瘤坏死因子家族B细胞活化因子(BAFF)在活动期系统性红斑狼疮T细胞中的表达:BAFF在T细胞依赖性B细胞致病性自身抗体产生中的作用。
Rheumatology (Oxford). 2007 Jul;46(7):1083-6. doi: 10.1093/rheumatology/kem097. Epub 2007 May 11.
8
Immunoglobulin production in vitro by peripheral blood lymphocytes in systemic lupus erythematosus: helper T cell defect and B cell hyperreactivity.系统性红斑狼疮患者外周血淋巴细胞体外免疫球蛋白的产生:辅助性T细胞缺陷与B细胞反应性亢进
Clin Exp Immunol. 1981 Jun;44(3):548-54.
9
The largely normal response to Toll-like receptor 7 and 9 stimulation and the enhanced expression of SIGIRR by B cells in systemic lupus erythematosus.系统性红斑狼疮患者对 Toll 样受体 7 和 9 的刺激反应基本正常,B 细胞中 SIGIRR 的表达增强。
PLoS One. 2012;7(8):e44131. doi: 10.1371/journal.pone.0044131. Epub 2012 Aug 29.
10
B cell hyperactivity is a function of T cell derived cytokines in systemic lupus erythematosus.在系统性红斑狼疮中,B细胞的过度活跃是T细胞衍生细胞因子作用的结果。
J Rheumatol. 1993 Nov;20(11):1885-91.

引用本文的文献

1
The Role of LAIR1 as a Regulatory Receptor of Antitumor Immune Cell Responses and Tumor Cell Growth and Expansion.LAIR1作为抗肿瘤免疫细胞反应以及肿瘤细胞生长与增殖的调节性受体的作用。
Biomolecules. 2025 Jun 13;15(6):866. doi: 10.3390/biom15060866.
2
Inhibitory pattern recognition receptors: lessons from LAIR1.抑制性模式识别受体:来自LAIR1的经验教训。
Nat Rev Immunol. 2025 May 27. doi: 10.1038/s41577-025-01181-2.
3
Is modulation of immune checkpoints on glioblastoma-infiltrating myeloid cells a viable therapeutic strategy?调节胶质母细胞瘤浸润性髓样细胞上的免疫检查点是否是一种可行的治疗策略?

本文引用的文献

1
CD5 expression in B cells from patients with systemic lupus erythematosus.系统性红斑狼疮患者B细胞中CD5的表达
Crit Rev Immunol. 2011;31(1):31-42. doi: 10.1615/critrevimmunol.v31.i1.30.
2
Antibody-mediated coengagement of FcγRIIb and B cell receptor complex suppresses humoral immunity in systemic lupus erythematosus.抗体介导的 FcγRIIb 和 B 细胞受体复合物的共交联抑制系统性红斑狼疮中的体液免疫。
J Immunol. 2011 Apr 1;186(7):4223-33. doi: 10.4049/jimmunol.1003412. Epub 2011 Feb 28.
3
Targeted therapies in systemic lupus erythematosus: successes, failures and future.
Neuro Oncol. 2025 Jan 12;27(1):33-49. doi: 10.1093/neuonc/noae193.
4
LAIR1, an ITIM-Containing Receptor Involved in Immune Disorders and in Hematological Neoplasms.LAIR1,一种包含 ITIM 的受体,与免疫紊乱和血液系统肿瘤有关。
Int J Mol Sci. 2022 Dec 17;23(24):16136. doi: 10.3390/ijms232416136.
5
Genetic dissection of TLR9 reveals complex regulatory and cryptic proinflammatory roles in mouse lupus.TLR9 的遗传剖析揭示了小鼠狼疮中复杂的调节和隐匿性促炎作用。
Nat Immunol. 2022 Oct;23(10):1457-1469. doi: 10.1038/s41590-022-01310-2. Epub 2022 Sep 23.
6
Complement System and Alarmin HMGB1 Crosstalk: For Better or Worse.补体系统与警报素 HMGB1 的串扰:有好有坏。
Front Immunol. 2022 Apr 28;13:869720. doi: 10.3389/fimmu.2022.869720. eCollection 2022.
7
Understanding the contextual functions of C1q and LAIR-1 and their applications.了解C1q和LAIR-1的上下文功能及其应用。
Exp Mol Med. 2022 May;54(5):567-572. doi: 10.1038/s12276-022-00774-4. Epub 2022 May 13.
8
Leukocyte Associated Immunoglobulin Like Receptor 1 Regulation and Function on Monocytes and Dendritic Cells During Inflammation.白细胞相关免疫球蛋白样受体 1 在炎症期间对单核细胞和树突状细胞的调节和功能。
Front Immunol. 2020 Aug 19;11:1793. doi: 10.3389/fimmu.2020.01793. eCollection 2020.
9
Immunoregulatory complement receptor-1 and leukocyte-associated Ig-like receptor-1 expression on leukocytes in .白细胞表面免疫调节补体受体 1 和白细胞相关免疫球蛋白样受体 1 的表达。
Innate Immun. 2020 Nov;26(8):683-692. doi: 10.1177/1753425920942570. Epub 2020 Jul 30.
10
Exome Sequencing Identifies Susceptibility Loci for Sarcoidosis Prognosis.外显子组测序鉴定出结节病预后的易感位点。
Front Immunol. 2019 Dec 24;10:2964. doi: 10.3389/fimmu.2019.02964. eCollection 2019.
系统性红斑狼疮的靶向治疗:成功、失败与未来。
Ann Rheum Dis. 2011 Mar;70 Suppl 1:i64-i66. doi: 10.1136/ard.2010.142208.
4
The genetics of systemic lupus erythematosus and implications for targeted therapy.系统性红斑狼疮的遗传学及其对靶向治疗的影响。
Ann Rheum Dis. 2011 Mar;70 Suppl 1:i37-43. doi: 10.1136/ard.2010.138057.
5
Novel treatments for systemic lupus erythematosus.系统性红斑狼疮的新型治疗方法。
Curr Opin Investig Drugs. 2010 Nov;11(11):1256-64.
6
The immune inhibitory receptor LAIR-1 is highly expressed by plasmacytoid dendritic cells and acts complementary with NKp44 to control IFNα production.免疫抑制性受体 LAIR-1 由浆细胞样树突状细胞高度表达,并与 NKp44 协同作用控制 IFNα 的产生。
PLoS One. 2010 Nov 30;5(11):e15080. doi: 10.1371/journal.pone.0015080.
7
Targeting B cells with biologics in systemic lupus erythematosus.针对系统性红斑狼疮中的 B 细胞的生物制剂治疗。
Expert Opin Biol Ther. 2010 Nov;10(11):1555-61. doi: 10.1517/14712598.2010.524923. Epub 2010 Oct 4.
8
Relevance of the mevalonate biosynthetic pathway in the regulation of bone marrow mesenchymal stromal cell-mediated effects on T-cell proliferation and B-cell survival.甲羟戊酸生物合成途径在骨髓间充质基质细胞介导的 T 细胞增殖和 B 细胞存活效应中的调节作用。
Haematologica. 2011 Jan;96(1):16-23. doi: 10.3324/haematol.2010.031633. Epub 2010 Sep 30.
9
SLE diagnosis and treatment: when early is early.SLE 的诊断和治疗:早期诊治。
Autoimmun Rev. 2010 Nov;10(1):55-60. doi: 10.1016/j.autrev.2010.08.014. Epub 2010 Sep 8.
10
Engagement of CD31 delivers an activating signal that contributes to the survival of chronic lymphocytic leukaemia cells.CD31 的交联传递一个激活信号,有助于慢性淋巴细胞白血病细胞的存活。
Br J Haematol. 2010 Nov;151(3):252-64. doi: 10.1111/j.1365-2141.2010.08343.x. Epub 2010 Aug 31.